aclidinium

	Next higher product group	bronchospasmolytics & asthma drugs_o
	Status	2012-09-30 sales start
	Organisation	Almirall S.A. (Spanish Stock Exchange: ALM)
	Group	Almirall (Group)

Record changed: 2023-07-10

Picture Berlin Partner Voices Robinson Data for Precision Medicine 650x200px

More documents for bronchospasmolytics & asthma drugs_o

[1] AstraZeneca plc. (11/1/21). "Press Release: AstraZeneca to Transfer Global Rights for Eklira and Duaklir to Covis Pharma"....
[2] Circassia Pharmaceuticals plc. (8/12/19). "Press Release: Circassia Appoints Industry Veteran Jonathan Emms as Chief Operating Officer". Oxford....
[3] GlaxoSmithKline plc. (7/24/17). "Press Release: GSK Submits US Regulatory Filing of Arnuity Ellipta in Children with Asthma"....
[4] AstraZeneca plc. (3/17/17). "Press Release: AstraZeneca and Circassia Enter Strategic Collaboration in Respiratory Disease"....
[5] Boehringer Ingelheim. (2/16/17). "Press Release: US FDA Expands Approval of Tiotropium Respimat for Maintenance Treatment of Asthma in Children". Ingelheim....
[6] AstraZeneca plc. (1/30/17). "Press Release: US FDA Approves Symbicort (budesonide/formoterol) for the Treatment of Asthma in Paediatric Patients"....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]